Insiders / Kaye Edward M. MD

Kaye Edward M. MD

CIK 1522780personinsider

Companies

3

First seen

Jan 16, 2026

Last activity

Jun 1, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Stoke Therapeutics, Inc. · STOK	Director	110,874	110,874	4	—
Cytokinetics Inc · CYTK	Director	10,283	13,216	5	—
Avidity Biosciences, Inc. · RNA	Director	0	0	8	—

All securities held

4 positions · latest reported per filing

Company	Security	Shares	As of
Cytokinetics Inc	Common Stock	10,283	Jun 1, 2026
Cytokinetics Inc	Non-Qualified Stock Option (Right to Buy)Derivative	4,301	May 27, 2026
Stoke Therapeutics, Inc.	Common Stock	110,874	Mar 15, 2026
Stoke Therapeutics, Inc.	Restricted Stock UnitsDerivative	52,500	Mar 15, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jun 1, 2026	Sell	CYTK Cytokinetics Inc Common Stock	$223.2K	-3K -22.19%	10,283 <0.01% of shares	medium
Jan 15, 2026	Grant	CYTK Cytokinetics Inc Common Stock	$12.5K	+197 +1.97%	10,174 <0.01% of shares	low
Apr 15, 2026	Grant	CYTK Cytokinetics Inc Common Stock	$12.5K	+191 +1.88%	10,365 <0.01% of shares	low
May 27, 2026	Grant	CYTK Cytokinetics Inc Common Stock	$0	+3K +27.51%	13,216 <0.01% of shares	low
Mar 15, 2026	Exercise	STOK Stoke Therapeutics, Inc. Common Stock	$0	+26K +31.02%	110,874 0.17% of shares	low
Mar 15, 2026	Exercise	STOK Stoke Therapeutics, Inc. Common Stock	$0	+36K +72.27%	84,624 0.13% of shares	low
May 27, 2026	Grant	CYTK Cytokinetics Inc Non-Qualified Stock Option (Right to Buy)	—	+4K	4,301 <0.01% of shares	low
Mar 15, 2026	Exercise	STOK Stoke Therapeutics, Inc. Restricted Stock Units	—	-26K -33.33%	52,500 0.08% of shares	low
Mar 15, 2026	Exercise	STOK Stoke Therapeutics, Inc. Restricted Stock Units	—	-36K -50.00%	35,500 0.06% of shares	low
Feb 27, 2026	Other	RNA Avidity Biosciences, Inc. Stock Option (Right to Buy)	—	-10K -100.00%	0 0.00% of shares	low